Public Release: 

New partnership provides free access to 6 vital neurology journals

Future Science Group has officially partnered 6 neurology titles with their new online resource, Neurology Central, offering all members unparalleled free access to peer-reviewed content

Future Science Group

Future Science Group (FSG) has announced that all articles from six of their top neurology journals will now be free to access for members of Neurology Central. The decision highlights the publisher's continued commitment to providing high-quality, accessible content to the neurology community.

The Neurology Collection, which is published by Future Medicine, an imprint of FSG, provides invaluable insight into the latest research and opinions across the broad field of neurology. The journal series includes titles dedicated to publishing the latest laboratory and clinical advances in neurodegenerative diseases, pain management and CNS oncology, along with many other key disease areas.

"Expanding access to key research is vital for facilitating progression and collaboration within the field of neurology. I am therefore very excited to announce this new step in improving access to these high-quality journals," commented Laura Dormer, Senior Manager of Commissioning & Journal Development (FSG).

The new partnership now enables Neurology Central to provide medical professionals with unique access to an expanding portfolio of free peer-reviewed content. Neurology Central members, individuals authoring for these six journals and new registrants to the site will receive immediate complete access to the full Neurology Collection, comprising CNS Oncology, Future Neurology, Neurodegenerative Disease Management, Neuropsychiatry, Pain Management and Concussion. Authors contributing to the journals will also benefit from increased dissemination and exposure of their work.

"This new partnership highlights one of many ways in which FSG is committed to bringing together the best talent and work for future scientific endeavor. We're very pleased to be championing new ways of increasing the accessibility of top research and opinion within the field," added Phil Garner, Managing Director (FSG).

Neurology Central will be exhibiting at SfN's Neuroscience 2015 (Booth #114) from 17- 21 October, and will be able to provide a full demonstration.

###

About Neurology Central

Providing users with a go-to hub for all the latest news and insight into key topics and issues in the field, membership to Neurology Central is completely free of charge. The site features daily news, exclusive opinion pieces and interviews with key opinion leaders, as well as high quality multimedia content, all of which is endorsed by an Expert Panel of researchers and clinicians from a range of different disciplines. Register online at http://www.neurology-central.com/register.

http://www.neurology-central.com

About Future Science Group

Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business FSG develops specialist eCommunities. Key titles and sites includes Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.

The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.

http://www.future-science-group.com | http://www.future-medicine.com | http://www.future-science.com

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.